Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Saltz

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Current Oncology Reports|April 29, 2010
Evolving treatment of advanced colorectal cancerAndrea Cercek, Leonard Saltz
Annals of Surgical Oncology|November 24, 2020
The Landmark Series: Chemotherapy for Non-Metastatic Colon CancerSalvador Alonso, Leonard Saltz
Current Treatment Options in Oncology|April 8, 2011
BEYOND KRAS: Other markers and potential treatment strategies for KRAS mutant and wild-type patientsAndrea Cercek, Leonard Saltz
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapyRona Yaeger, Leonard Saltz
Journal of the National Comprehensive Cancer Network : JNCCN|November 6, 2007
Targeted strategies in the treatment of metastatic colon cancerDiane Reidy, Leonard Saltz
Gastroenterology Clinics of North America|March 4, 2008
Systemic therapy for colon cancerTimothy R Asmis, Leonard Saltz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?Román Peréz-Soler, Leonard Saltz
Nature Reviews. Drug Discovery|January 4, 2007
PanitumumabLeonard Saltz, Chris Easley, Peter Kirkpatrick
Seminars in Oncology|September 20, 2017
Commentary: Somatostatin analogs-How we choose, and whyDiane Reidy-Lagunes, Nitya Raj, Leonard Saltz
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2009
Anal canal cancer. Clinical practice guidelines in oncologyPaul F Engstrom, Al B Benson, Leonard Saltz, et al.
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Current Oncology Reports|April 29, 2010
Evolving treatment of advanced colorectal cancerAndrea Cercek, Leonard Saltz
Annals of Surgical Oncology|November 24, 2020
The Landmark Series: Chemotherapy for Non-Metastatic Colon CancerSalvador Alonso, Leonard Saltz
Current Treatment Options in Oncology|April 8, 2011
BEYOND KRAS: Other markers and potential treatment strategies for KRAS mutant and wild-type patientsAndrea Cercek, Leonard Saltz
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapyRona Yaeger, Leonard Saltz
Journal of the National Comprehensive Cancer Network : JNCCN|November 6, 2007
Targeted strategies in the treatment of metastatic colon cancerDiane Reidy, Leonard Saltz
Gastroenterology Clinics of North America|March 4, 2008
Systemic therapy for colon cancerTimothy R Asmis, Leonard Saltz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?Román Peréz-Soler, Leonard Saltz
Nature Reviews. Drug Discovery|January 4, 2007
PanitumumabLeonard Saltz, Chris Easley, Peter Kirkpatrick
Seminars in Oncology|September 20, 2017
Commentary: Somatostatin analogs-How we choose, and whyDiane Reidy-Lagunes, Nitya Raj, Leonard Saltz
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2009
Anal canal cancer. Clinical practice guidelines in oncologyPaul F Engstrom, Al B Benson, Leonard Saltz, et al.
Pageof 17